| Primary |
| Hypertension |
40.8% |
| Product Used For Unknown Indication |
18.5% |
| Drug Use For Unknown Indication |
12.3% |
| Cardiac Failure |
5.4% |
| Cardiac Failure Chronic |
4.9% |
| Type 2 Diabetes Mellitus |
4.0% |
| Essential Hypertension |
3.2% |
| Pain |
1.3% |
| Diabetes Mellitus |
1.3% |
| Atrial Fibrillation |
1.2% |
| Cardiac Failure Congestive |
1.0% |
| Gastritis |
0.8% |
| Blood Pressure Increased |
0.7% |
| Depression |
0.7% |
| Chronic Obstructive Pulmonary Disease |
0.7% |
| Prophylaxis |
0.7% |
| Coronary Artery Disease |
0.6% |
| Hyperuricaemia |
0.6% |
| Thrombosis Prophylaxis |
0.6% |
| Back Pain |
0.6% |
|
| Renal Failure Acute |
17.6% |
| Angioedema |
13.4% |
| Vomiting |
10.0% |
| Renal Failure |
5.1% |
| Swollen Tongue |
4.9% |
| Syncope |
4.9% |
| Hyperkalaemia |
4.2% |
| Hypoglycaemia |
4.2% |
| Drug Interaction |
3.8% |
| Dyspnoea |
3.3% |
| Hyponatraemia |
3.3% |
| Swelling Face |
3.3% |
| Weight Decreased |
3.1% |
| Cough |
2.9% |
| Completed Suicide |
2.7% |
| Hypotension |
2.7% |
| Tachycardia |
2.7% |
| White Blood Cell Count Increased |
2.7% |
| Fall |
2.5% |
| Interstitial Lung Disease |
2.5% |
|
| Secondary |
| Cardiac Failure |
31.7% |
| Cardiac Failure Chronic |
14.4% |
| Hypertension |
13.2% |
| Product Used For Unknown Indication |
7.6% |
| Drug Use For Unknown Indication |
4.8% |
| Cardiac Failure Congestive |
4.1% |
| Diabetes Mellitus |
3.2% |
| Type 2 Diabetes Mellitus |
3.0% |
| Atrial Fibrillation |
2.3% |
| Prophylaxis |
2.0% |
| Insomnia |
1.6% |
| Hyperuricaemia |
1.6% |
| Hyperlipidaemia |
1.5% |
| Myocardial Infarction |
1.5% |
| Glaucoma |
1.4% |
| Thrombosis Prophylaxis |
1.3% |
| Bacteraemia |
1.3% |
| Myocardial Ischaemia |
1.2% |
| Cardiovascular Disorder |
1.2% |
| Depression |
1.2% |
|
| Renal Failure Acute |
12.3% |
| Concomitant Disease Progression |
10.1% |
| Renal Failure |
7.7% |
| Cardiac Failure |
7.4% |
| Hypotension |
6.4% |
| Completed Suicide |
5.7% |
| Vomiting |
5.7% |
| Hyperkalaemia |
4.4% |
| Disease Progression |
4.3% |
| Toxic Epidermal Necrolysis |
4.3% |
| Renal Impairment |
4.0% |
| Hyponatraemia |
3.9% |
| Syncope |
3.7% |
| Dyspnoea |
3.6% |
| Condition Aggravated |
3.4% |
| Cardiac Failure Acute |
2.9% |
| Urinary Tract Infection |
2.7% |
| Orthostatic Hypotension |
2.6% |
| Death |
2.4% |
| Lactic Acidosis |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Hypertension |
19.5% |
| Drug Use For Unknown Indication |
18.9% |
| Rheumatoid Arthritis |
5.7% |
| Diabetes Mellitus |
5.5% |
| Pain |
3.3% |
| Prophylaxis |
3.3% |
| Type 2 Diabetes Mellitus |
3.2% |
| Depression |
2.4% |
| Atrial Fibrillation |
2.3% |
| Osteoporosis |
1.9% |
| Blood Cholesterol Increased |
1.6% |
| Blood Pressure |
1.5% |
| Cardiac Disorder |
1.5% |
| Cardiac Failure |
1.4% |
| Hiv Infection |
1.4% |
| Chronic Obstructive Pulmonary Disease |
1.4% |
| Multiple Myeloma |
1.3% |
| Hepatitis C |
1.2% |
| Insomnia |
1.0% |
|
| Vomiting |
15.3% |
| Weight Decreased |
8.6% |
| Myocardial Infarction |
7.3% |
| Urinary Tract Infection |
5.2% |
| Renal Failure Acute |
5.1% |
| Weight Increased |
5.1% |
| Pneumonia |
4.8% |
| Renal Failure |
4.7% |
| Syncope |
4.5% |
| Pain |
4.3% |
| Nausea |
3.9% |
| Drug Ineffective |
3.8% |
| Death |
3.8% |
| Pyrexia |
3.7% |
| Rhabdomyolysis |
3.4% |
| Thrombocytopenia |
3.4% |
| Sepsis |
3.3% |
| Dyspnoea |
3.3% |
| Rash |
3.3% |
| Tremor |
3.2% |
|
| Interacting |
| Hypertension |
37.6% |
| Type 2 Diabetes Mellitus |
12.5% |
| Cardiac Failure |
8.5% |
| Drug Use For Unknown Indication |
7.5% |
| Atrial Fibrillation |
4.4% |
| Pain |
3.6% |
| Product Used For Unknown Indication |
3.6% |
| Hyperlipidaemia |
2.6% |
| Ischaemic Heart Disease Prophylaxis |
2.6% |
| Diabetes Mellitus |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Glaucoma |
2.2% |
| Hypothyroidism |
1.6% |
| Prophylaxis |
1.6% |
| Venous Insufficiency |
1.6% |
| Anxiety |
1.4% |
| Blood Pressure |
1.2% |
| Heart Rate |
1.2% |
| Coronary Artery Disease |
1.0% |
| Dyslipidaemia |
1.0% |
|
| Renal Failure Acute |
38.6% |
| Drug Interaction |
10.2% |
| Hyperkalaemia |
9.1% |
| Hypoglycaemia |
6.8% |
| Therapeutic Agent Toxicity |
6.8% |
| Pneumonia |
4.5% |
| Angioedema |
2.3% |
| Hyponatraemia |
2.3% |
| Metabolic Acidosis |
2.3% |
| Renal Impairment |
2.3% |
| Tinnitus |
2.3% |
| Transient Global Amnesia |
2.3% |
| Vomiting |
2.3% |
| Acute Prerenal Failure |
1.1% |
| Atrioventricular Block |
1.1% |
| Blood Creatinine Increased |
1.1% |
| Blood Potassium Increased |
1.1% |
| Blood Pressure Abnormal |
1.1% |
| Bradycardia |
1.1% |
| Dehydration |
1.1% |
|
